<DOC>
	<DOC>NCT02953639</DOC>
	<brief_summary>This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable CIAS participants treated with antipsychotics.</brief_summary>
	<brief_title>A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosis of schizophrenia of any type utilizing the Mini International Neuropsychiatric Interview (MINI) and diagnostic and statistical manual of mental disorders, fifth edition, (DSM5) direct clinical assessments, family informants and past medical records Evidence of stability of symptoms for 3 months at screening, that is (i.e.), without hospitalizations for schizophrenia or increase in level of psychiatric care due to worsening of symptoms of schizophrenia Participants with schizophrenia clinical symptom severity defined by the following: hallucinatory behavior item score less than or equal to (&lt;/=) 5 and a delusion item score &lt;/= 5 of the PANSS Participants on a stable regimen of antipsychotic therapy for at least 3 months at screening and receiving no more than two antipsychotics Participants with current DSM5 diagnosis other than schizophrenia including bipolar disorder, schizoaffective disorder and major depressive disorder (MDD) Clinically significant neurological illness or significant head trauma that affects cognitive function, in the judgment of the principal investigator Full scale intelligence quotient (FSIQ) &lt;70 on the Wechsler Abbreviated Scale of Intelligence (WASIII) at screening Positive result at screening for hepatitis B (HBV), hepatitis C (HCV), or human immunodeficiency virus (HIV)1 and 2 Moderate to severe substance use disorder (other than nicotine or caffeine), as defined by the DSM5, within the last 12 months Suicide attempt within one year or currently at risk of suicide in the opinion of the Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>